CHEUF Financials 07/17/2014 23:09:30
CHEUF Financials 07/17/2014 23:09:30
Cheung Kong (HOLDINGS) Ltd.
Period Ending
Total Revenue
Cost of Revenue
Gross Profit
Operating Expenses
Research and Development
Sales, General and Admin.
Non-Recurring Items
Other
Operating Income
Income From Continuing Operations
Add'l Income/Expense Items
Earnings Before Interest and Tax
Interest Expense
Earnings Before Tax
Income Tax
Minority Interest
Equity Earnings Unconsolidated Subsidiary
Net Income Cont. Operations
Non Recurring Events
Discontinued Operations
Extraordinary Items
Effect of Accounting Changes
Other Items
Net Income
Preferred Stock and Other Adjustments
Net Income Applicable to Common Shareholders
Scroll down for more posts ▼
Top 10 Most Recent News Articles
Festo's Pneumatic Safety Game-Changer Festo is stirring up quite a fuss at the Automation Fair in Boston this year, and it's not just hot air. Their new CPX-AP-A CIP Safety module is a standout. This jolt of innovation is geared to revolutionize the way safety is approached in pneumatic systems. The key? Seamless integration and robust performance, not to mention a...
Continue Reading
Transforming AI from Cost to Profit Alright folks, we all know AI's the flashy tool everyone's jumping on like it's the latest tech bandwagon. But here’s the raw deal: most of these shiny AI investments ain't paying back a damn thing. Enter the AI Adoption Institute (AiAi)—a new player in Denver aiming to salvage this mess and make AI about actual returns. Peering...
Continue Reading
Innovative Moves in Bioprocessing Let's get one thing clear right off the bat—CPC Biotech, part of Dover (NYSE: DOV), just sent a signal loud and clear with their new Quattroflow HTX all-in-one pump drive. With a slick touchscreen, flexible control options, and self-touting accuracy, this thing sounds like it's set to change the game for biopharmaceutical processing....
Continue Reading
The Unsettling News for O-I Glass Investors Let me dive right into this mess about O-I Glass, Inc. (NYSE:OI). If you're tangled up in their stock, you probably felt that 15.01% nosedive in your portfolio recently. That's no minor blip. On July 28, 2026, as stocks were virtually put through the shredder, O-I Glass announced they had to cut down their financial guidance for...
Continue Reading
The Subtle Slowdown in Vision When it comes to cataracts, things don't just suddenly hit you like a ton of bricks. It’s a slow burn—cataracts develop over months or even years. Your vision starts feeling like it’s giving up on high definition. The lens in your eye starts to get cloudy, like a fog rolling in on a morning drive. You're not going to wake up one day...
Continue Reading
Replit's Triumph in the Microsoft Ecosystem If there's one thing you come to expect from this dizzying dance of technology and business, it's that standout players get their due when they push the envelope. Replit just snagged a gleaming accolade by being named Microsoft's 2026 Partner of the Year for Startups. That's a hefty badge, especially coming from a giant like...
Continue Reading
The Spirit of Golf Meets Enterprise Well, folks, Palm Beach Atlantic University is rolling out the red carpet for two very different, yet equally successful figures in the world of golf. On November 17, their 42nd annual American Free Enterprise Day will recognize Jack Nicklaus, the indomitable Golden Bear, and Grant Horvat, a fresh face and driving force in the golf...
Continue Reading
Billings Dives into the Swim School Scene Well, folks, Billings is about to get its feet wet with something new and well-needed in the local scene. Come November 21, Montana will welcome its first dedicated swim school as Water Wings opens shop right here in Billings at 2618 King Ave W. This ain't just run-of-the-mill comic relief on disaster-preparedness. We're talking...
Continue Reading
QFIN Executives in Legal Hot Water Qfin Holdings, Inc. (NASDAQ: QFIN) is in a tight spot as a securities class action lawsuit casts a harsh spotlight on its senior executives. The CEO and CFO, during the contested class period, are front and center in this legal tangle. Qfin's stockholders are grappling with losses, and it's all tied back to some certified SEC filings...
Continue Reading
What's Going on with Elypta? Well, isn't this an intriguing twist in cancer risk prediction? A Swedish company, Elypta, just tossed its hat into the medicinal ring with some fascinating findings. They're leveraging a study that analyzes urine biomarkers to predict cancer risk over a five-year span. Tackling a whopping cohort of 5,436 adults, it's as ambitious as it...
Continue Reading
Top 5 Most Recently Viewed Articles
Overview of Total Voting Rights and Capital Octopus AIM VCT plc is pleased to share important details regarding its share capital and voting rights, essential information which benefits all shareholders looking to understand their position within the company. Current Share Capital Structure As of the end of September, the company's issued share capital is comprised of...
Continue Reading
Gewan Hotels & Resorts Expands Horizons in Egypt It's official—Gewan is making waves by entering Egypt with a bold new venture. This expansion is not just significant; it's transformative for the hospitality landscape. Gewan Hotels & Resorts is a proud subsidiary of NG9 Holding, and it has officially unveiled plans to enter the vibrant Egyptian hospitality market by...
Continue Reading
Joyburst Introduces Exciting New Flavor in Collaboration with Disney Joyburst, known for their commitment to craft delicious beverages, is thrilled to announce the release of a new flavor in their premium hydration lineup: Tropical Fruit Punch. This vibrant offering blends tropical tastes, enhancing their current flavors of Peach, Watermelon, and Strawberry-Lemonade....
Continue Reading
FDA Approval Update for Travere Therapeutics In an important milestone for kidney disease treatment, the U.S. Food and Drug Administration (FDA) approved an update to the Risk Evaluation and Mitigation Strategy (REMS) for Travere Therapeutics, Inc.’s Filspari (sparsentan). This approval marks Filspari as the only Dual Endothelin Angiotensin Receptor Antagonist...
Continue Reading
Important Deadline for Orthofix Medical Inc. Investors If you’re an investor based in Los Angeles, pay attention to a crucial deadline related to the class action lawsuit against Orthofix Medical Inc. If you bought shares or obtained common stock during a specified time frame, you might be eligible to seek recovery. The time to file a lead plaintiff motion is quickly...
Continue Reading